Free tool
FAERS Monitor: Omeprazole
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209400 or its brand name (Omeprazole, Omeprazole). Reports on generic versions are filed under their own applications.
Reports
349,830
Serious
257,870
74% of reports
Hospitalization
127,821
Death reported
31,667
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue21,081
- nausea21,009
- diarrhoea20,814
- dyspnoea17,286
- drug ineffective16,663
- headache15,621
- pain14,599
- chronic kidney disease14,128
- vomiting14,011
- dizziness13,943
- off label use13,640
- acute kidney injury12,307
- malaise11,464
- arthralgia11,309
- fall11,179
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,484 |
| 2005 | 3,085 |
| 2006 | 3,080 |
| 2007 | 3,247 |
| 2008 | 4,328 |
| 2009 | 5,458 |
| 2010 | 7,438 |
| 2011 | 9,825 |
| 2012 | 12,809 |
| 2013 | 12,142 |
| 2014 | 14,808 |
| 2015 | 21,189 |
| 2016 | 23,502 |
| 2017 | 22,186 |
| 2018 | 28,715 |
| 2019 | 32,211 |
| 2020 | 25,702 |
| 2021 | 22,376 |
| 2022 | 21,235 |
| 2023 | 20,124 |
| 2024 | 19,421 |
| 2025 | 19,837 |
| 2026 | 14,619 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,704,329 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 14,128 | 13.5 | 13.3 | 133,635 |
| acute kidney injurySignal | 12,307 | 5.2 | 5.1 | 38,345 |
| fallSignal | 11,179 | 2.1 | 2.0 | 5,943 |
| diarrhoea | 20,814 | 2.0 | 1.9 | 9,923 |
| dyspnoea | 17,286 | 1.9 | 1.8 | 6,874 |
| vomiting | 14,011 | 1.8 | 1.8 | 5,097 |
| dizziness | 13,943 | 1.7 | 1.7 | 4,003 |
| arthralgia | 11,309 | 1.7 | 1.6 | 2,895 |
| fatigue | 21,081 | 1.6 | 1.6 | 5,392 |
| nausea | 21,009 | 1.6 | 1.6 | 4,940 |
| malaise | 11,464 | 1.6 | 1.6 | 2,474 |
| headache | 15,621 | 1.5 | 1.5 | 2,710 |
| pain | 14,599 | 1.4 | 1.4 | 1,968 |
| off label use | 13,640 | 0.9 | 0.9 | 62 |
| drug ineffective | 16,663 | 0.8 | 0.7 | 1,368 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.